SCHEMBL893803

SCHEMBL893803

O=C(Cl)c1ccc(-c2ccc(C(=O)Cl)c(C(=O)Cl)c2)cc1C(=O)Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
GFER P55789 1/20 0.43
KMT2A Q03164 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ALDH1A1 P00352 1/20 0.39
ALOX15 P16050 1/20 0.39
ACMSD Q8TDX5 4/20 0.39
MCL1 Q07820 3/20 0.39
HNF4A P41235 2/20 0.39
DHFR P00374 1/20 0.39
CFD P00746 1/20 0.36
IKBKB O14920 1/20 0.36
LCK P06239 1/20 0.36
GSTA1 P08263 1/20 0.35
DCLRE1A Q6PJP8 1/20 0.34
DCLRE1B Q9H816 1/20 0.34
PPM1B O75688 1/20 0.34
HSD17B1 P14061 1/20 0.34
CHUK O15111 1/20 0.34
ERCC5 P28715 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11037121 0.89 ACMSD (0.55) ACMSDMCL1HNF4ADHFRIKBKB
SCHEMBL28460186 0.88 KDM4E (0.54) KDM4EGFERKMT2ARXFP1ALDH1A1
SCHEMBL9153003 0.78 MCL1 (0.48) KDM4EGFERKMT2ARXFP1ALDH1A1
SCHEMBL4365448 0.78 RXRB (0.53) ALDH1A1ALOX15ACMSDMCL1HNF4A
SCHEMBL654794 0.77 ALDH1A1 (0.52) KDM4EALDH1A1ERCC5FEN1
SCHEMBL11039562 0.77 CES2 (0.50) KDM4EGFERKMT2AALDH1A1ALOX15
SCHEMBL75886 0.77 ALDH1A1 (0.40) KDM4EALDH1A1ALOX15
SCHEMBL29440655 0.77 ALDH1A1 (0.40) KDM4EALDH1A1ALOX15
SCHEMBL28874983 0.77 ALDH1A1 (0.38) ALDH1A1ALOX15ACMSDMCL1HNF4A
SCHEMBL9154092 0.77 RXRB (0.47) KDM4EGFERKMT2ARXFP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111675628-A 3,3',4,4' -biphenyl tetracarboxyl tetraoctylamine and preparation method and application thereof 新岸诺亚(北京)催化科技有限公司 2020-09-18 CN disclosed
CN-111662201-A 3,3',4,4' -biphenyl tetra-formyl tetra-alkylamine and preparation method and application thereof 新岸诺亚(北京)催化科技有限公司 2020-09-15 CN disclosed
EP-2498136-B1 Intermediate transfer belt and image forming apparatus using the same RICOH CO LTD (JP) 2018-05-02 EP disclosed
EP-2982731-B1 PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORP (JP) 2017-11-08 EP disclosed
EP-2982731-B1 PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORP (JP) 2017-11-08 EP disclosed
US-9643924-B2 Piperidine derivative, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2017-05-09 US disclosed
US-9643924-B2 Piperidine derivative, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2017-05-09 US disclosed
US-9643924-B2 Piperidine derivative, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2017-05-09 US disclosed
US-20160039758-A1 PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2016-02-11 US disclosed
US-20160039758-A1 PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2016-02-11 US disclosed
US-20160039758-A1 PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC PETROCHEMICAL CORPORATION (JP) 2016-02-11 US disclosed
EP-2982731-A1 PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2016-02-10 EP disclosed
EP-2982731-A1 PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC Corporation (JP) 2016-02-10 EP disclosed
US-8521073-B2 Intermediate transfer member and image forming apparatus using the same RICOH COMPANY, LTD. (JP) 2013-08-27 US disclosed
US-20120230740-A1 INTERMEDIATE TRANSFER BELT AND IMAGE FORMING APPARATUS USING THE SAME RICOH COMPANY, LTD. (JP) 2012-09-13 US disclosed
EP-2498136-A1 Intermediate transfer belt and image forming apparatus using the same Ricoh Company, Ltd. (JP) 2012-09-12 EP disclosed
US-20120082488-A1 INTERMEDIATE TRANSFER MEMBER AND IMAGE FORMING APPARATUS USING THE SAME RICOH COMPANY, LTD. (JP) 2012-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039758-A1 PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE DRD1, PLD1, CCND1 KDM4E 2646/4885GFER 4431/4885KMT2A 1730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.